Canada Markets open in 6 hrs 55 mins

PharmaTher Holdings Ltd. (PHRM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.7900-0.0500 (-5.95%)
At close: 3:59PM EDT
Full screen
Previous Close0.8400
Open0.0000
Bid0.7700 x N/A
Ask0.8000 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume306,828
Market Cap53.778M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

    10 clinical sites selected to participate in the FDA Phase 2 clinical study evaluating ketamine for the treatment of Parkinson’s DiseaseInitiated investigational new drug (IND) application to proceed to a Phase 2 clinical study for KETABET™ to treat depressionCompleted Phase 2 clinical study protocol for ketamine to treat ALS for IND submission to the FDANear completion of research programs to advance novel microneedle patches for the delivery of psychedelicsSelected U.S.-based CDMO to develop a

  • GlobeNewswire

    PharmaTher to Present at H.C. Wainwright 23rd Annual Global Investment Conference

    To provide an update on PharmaTher’s product pipeline and upcoming milestones on its FDA Phase 2 clinical studies and microneedle patch programs involving ketamine and psychedelics TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce its participation in the H.C. Wainwright 23rd Annual Global Investment Conference (“the Conference”), taking place virtu

  • GlobeNewswire

    PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021

    TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today released business highlights and financial results for its fiscal year ended May 31, 2021. Unless otherwise indicated, all amounts in this press release are in Canadian dollars. Fabio Chianelli, Chief Executive Officer of PharmaTher, said, “We had a tremendous year which focused on solidifying exclusive licenses for